Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Diabetic nephropathies

Kiritoshi S, Nishikawa T, Sonoda K, Kukidome D, Senokuchi T, Matsuo T, Matsumura T, Tokunaga H, Brownlee M, Araki E (2003) Reactive oxygen species from mitochondria induce cyclooxygenase-2 gene expression in human mesangial cells potential role in diabetic nephropathy. Diabetes 52 2570-2577. [Pg.76]

American Diabetes Association. Diabetic nephropathy. Diabetes Care 2003 26 594-8. [Pg.617]

Facchini, F.S. and Saylor, K.L., A low-iron-available, polyphenol-enriched, carbohydrate-restricted diet to slow progression of diabetic nephropathy. Diabetes, 52, 1204, 2003. [Pg.368]

Imano E, Kanda T, Nakatani Y, Nishida T, Arai K, Motomura M, Kajimoto Y, Yamasaki Y, Hori M. Effect of troglitazone on microalbuminuria in patients with incipient diabetic nephropathy. Diabetes Care 1998 21(12) 2135-9. [Pg.469]

Yasuda G, Hasegawa K, Kuji T, et al. Effects of doxazosin on ambulatory blood pressure and sympathetic nervous activity in hypertensive type 2 diabetic patients with overt nephropathy. Diabet Med. 2005 22 1394-1400. [Pg.305]

Plasma Diabetes without nephropathy, diabetic nephropathy III, IV, and V Healthy subjects 50 patients 88 HPLC-UV- MS/MS Adenosine, inosine, uric acid, xanthine, and creatinine (44)... [Pg.296]

Rossing K, Schjoedt KJ, Smidt UM, Boomsma F, Parving HH. Beneficial effects of adding spironolactone to recommended anti-hypertensive treatment in diabetic nephropathy. Diabetes Care 2005 28 2106-2112. [Pg.505]

Yaqoob M, Patrick AW, McClelland P, Stevenson A, Mason H, Percy DF, White MC, Bell GM. Occupational hydrocarbon exposure in diabetic nephropathy. Diabetic Med 1994 11(8) 789-793. [Pg.838]

Molitch ME, DeFronzo RA, Franz MJ, Keane WF, Mogensen CE, Parving HH. Diabetic nephropathy. Diabetes Care 2003 26 Suppl l S94-8. ... [Pg.897]

Sawicki PT, Didjurgeit U, Muhlhauser I, et al. Smoking is associated with progression of diabetic nephropathy. Diabetes Care 1994 17 126-131. [Pg.818]

Fageradd 1, Forsblom C, Pettersson-Femholm K, Groop PH. Implementation of guidehnes for the prevention of diabetic nephropathy. Diabetes Care 2004 27 803-804. [Pg.224]

Pedchenko VK, Chetyrkin 8V, Chuang P, et al. Mechanism of perturbation of integrin-mediated cell-matrix interactions by reactive carbonyl compounds and its implication for pathogenesis of diabetic nephropathy. Diabetes 2005 54 2952-2960. [Pg.226]

Sustzak K, Raff AC, Schiffer M, and Bottinger EP. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes, 55 225-231 (2006). [Pg.180]

Lewis, E.J. and X. Xu, 2008. Abnormal glomerular permeability characteristics in diabetic nephropathy. Diabetes Care 31, 202-207. [Pg.252]


See other pages where Diabetic nephropathies is mentioned: [Pg.1869]    [Pg.3386]    [Pg.116]    [Pg.107]    [Pg.205]    [Pg.281]    [Pg.193]   
See also in sourсe #XX -- [ Pg.150 ]

See also in sourсe #XX -- [ Pg.263 ]

See also in sourсe #XX -- [ Pg.263 ]

See also in sourсe #XX -- [ Pg.163 ]

See also in sourсe #XX -- [ Pg.263 ]

See also in sourсe #XX -- [ Pg.859 ]




SEARCH



Angiotensin-converting enzyme diabetic nephropathy

Angiotensin-converting enzyme inhibitors diabetic nephropathy treatment

Captopril diabetic nephropathy treatment

Diabetes mellitus nephropathy

Diabetic nephropathy management

Diabetic nephropathy risk factors

Diabetic nephropathy urine albumin

Kidney disease diabetic nephropathy

Nephropathy

Renal disease diabetic nephropathy

© 2024 chempedia.info